The Role of Crypt Fissioning in IBD Ulcer Healing
The Role of Crypt Fissioning in IBD Ulcer Healing
批准号:
10358590
负责人:
Terrence A. Barrett
金额:
$66.28万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-02-24 至 2025-01-31
关键词:
BiochemicalBiogenesisBiopsyChildhoodChronicClinicalClinical DataClinical ResearchColitisCrohn&aposs diseaseDataDiseaseDisease OutcomeDisease remissionDropsEpithelial CellsFailureGene ExpressionGenerationsGenesGenetic TranscriptionGenetically Engineered MouseGoalsHumanIn VitroInflammationInflammatory Bowel DiseasesInjuryIntestinesInvestigationKnockout MiceLeukocyte L1 Antigen ComplexMaintenanceMeasuresMitochondriaModelingMonoclonal AntibodiesMucositisMucous MembraneMusOperative Surgical ProceduresOutcomeOxidation-ReductionPTEN genePathogenesisPatientsPhosphatidylinositolsPhosphotransferasesPrincipal InvestigatorProceduresRefractoryRespirationRespiratory ChainRoleSignal TransductionSiteTNF geneTattooingTestingTreatment EfficacyUlcerUlcerative ColitisVisualizationWNT Signaling PathwayWorkbasebeta cateninchronic ulcerclinical phenotypecrypt celldextran sulfate sodium induced colitisdrug developmentexperiencehealinginfliximabintestinal epitheliumnew therapeutic targetnovelnovel strategiespreventprogramsprospectiverepairedresponsesingle-cell RNA sequencingstem cellstherapeutic biomarkertherapeutic targettranscriptomics
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Program Director/Principal Investigator (Barrett, Terrence, A):
The importance of mucosal healing in inflammatory bowel disease (IBD) derives from clinical data that
demonstrate it to be a predictor of remission1. Thus, ulcer healing predicts the capacity for therapies to prevent
unwanted clinical sequelae (i.e. surgery). Unfortunately, many IBD patients remain refractory or lose
responsiveness to therapies leading to persistent mucosal ulceration. Prospective pediatric studies show that
reduced mitochondrial gene expression predict unfavorable outcomes in ulcerative colitis (UC)2. These findings
were supported by Kugathasan et al who found that increased expression of mitochondrial respiratory chain
genes predicted favorable (B1 protected) Crohn’s disease (CD) outcomes3. Based on these results and our
own data, we hypothesize that a critical driver of chronic ulceration in IBD is the failure of intestinal
epithelial cells (IEC) to increase mitochondrial respiration with ROS generation. We posit that chronic
mucosal inflammation suppresses mitochondrial respiration needed for crypt fissioning (in ulcer healing) in
IBD. This hypothesis will be tested in the following studies: Aim 1. Determine the impact of
mitochondrial respiration for mucosal healing. These studies benefit from strikingly novel Prelim.
Data using VilCre/mTmG/TFAMfl/fl mice where mitochondrial respiration was shown to be required for
crypt fissioning in ulcer healing. In Aim 2 we will determine the requirement of mitochondrial-
derived ROS in IEC crypt division using primary human colonoids. Aim 3 studies will determine
the impact of chronic inflammation on ulcer healing in patients. IEC transcriptomics from ulcer
edges from CD and ulcerative colitis will be compared to normal ulcer healing. Normal ulcer healing
will be interrogated using a novel biopsy of a biopsy (Bx/Bx) approach (IEC will be isolated from
Bx/Bx sites 4-6day after initial biopsies). ScRNAseq results have already shown that mitochondrial
biogenesis (PGC1) increases in Bx/Bx ulcers whereas levels drop in IBD IEC. In summary: Studies
will investigate the cause of non-healing ulceration in IBD by interrogating novel murine, human
and in vitro colonoid culture models of determining the impact of suppressed mitochondrial respiration
on IEC responses (crypt fissioning). The studies will test the notion that chronic mucosal
inflammation (as in IBD) suppresses mitochondrial respiration which impedes ROS-induced
PI3K signaling and crypt fissioning. Our goal is to identify therapeutic targets to allow for enhanced
mitochondrial respiration to aide mucosal repair in IBD.
OMB No. 0925-0001/0002 (Rev. 01/18 Approved Through 03/31/2020) Page Continuation Format Page
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Role of Crypt Fissioning in IBD Ulcer Healing
-
批准号:10609794
-
项目类别:
-
资助金额:$66.15万
-
财政年份:2021
-
负责人:Terrence A. Barrett
-
依托单位:
Peripheral Blood Exosome Lipids as Biomarkers of Disease Activity in Crohn’s Disease
-
批准号:9767782
-
项目类别:
-
资助金额:$19.27万
-
财政年份:2018
-
负责人:Terrence A. Barrett
-
依托单位:
Modulation of mitochondrial respiration to treat colitis
-
批准号:10560494
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:Terrence A. Barrett
-
依托单位:
Modulation of mitochondrial respiration to treat colitis
-
批准号:10367171
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:Terrence A. Barrett
-
依托单位:
The role of Axin2+ stem cells in ulcer healing during colitis.
-
批准号:9138122
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:Terrence A. Barrett
-
依托单位:
Regulation of Intestinal Stem Cell Activation in Colitis
-
批准号:8893972
-
项目类别:
-
资助金额:$30.84万
-
财政年份:2013
-
负责人:Terrence A. Barrett
-
依托单位:
Regulation of Intestinal Stem Cell Activation in Colitis
-
批准号:8693314
-
项目类别:
-
资助金额:$30.74万
-
财政年份:2013
-
负责人:Terrence A. Barrett
-
依托单位:
Regulation of Intestinal Stem Cell Activation in Colitis
-
批准号:8441348
-
项目类别:
-
资助金额:$32.7万
-
财政年份:2012
-
负责人:Terrence A. Barrett
-
依托单位:
Lymphoepithelial interactions in IBD
-
批准号:7388886
-
项目类别:
-
资助金额:$32.28万
-
财政年份:2005
-
负责人:Terrence A. Barrett
-
依托单位:
Lymphoepithelial interactions in IBD
-
批准号:7173828
-
项目类别:
-
资助金额:$32.9万
-
财政年份:2005
-
负责人:Terrence A. Barrett
-
依托单位:
Lymphoepithelial interactions in IBD
-
批准号:6972954
-
项目类别:
-
资助金额:$18.64万
-
财政年份:2005
-
负责人:Terrence A. Barrett
-
依托单位:
Lymphoepithelial interactions in IBD
-
批准号:7568779
-
项目类别:
-
资助金额:$32.28万
-
财政年份:2005
-
负责人:Terrence A. Barrett
-
依托单位:
Lymphoepithelial interactions in IBD
-
批准号:7104345
-
项目类别:
-
资助金额:$33.88万
-
财政年份:2005
-
负责人:Terrence A. Barrett
-
依托单位:
IBD Research--Junior Faculty Symposium
-
批准号:6427929
-
项目类别:
-
资助金额:$0.4万
-
财政年份:2002
-
负责人:Terrence A. Barrett
-
依托单位:
T CELL ACTIVATION AND CRYPT CELL APOPTOSIS
-
批准号:6476259
-
项目类别:
-
资助金额:$27.81万
-
财政年份:1999
-
负责人:Terrence A. Barrett
-
依托单位:
T CELL ACTIVATION AND CRYPT CELL APOPTOSIS
-
批准号:2729528
-
项目类别:
-
资助金额:$24.66万
-
财政年份:1999
-
负责人:Terrence A. Barrett
-
依托单位:
T cell activation and crypt cell apoptosis
-
批准号:7230352
-
项目类别:
-
资助金额:$12.5万
-
财政年份:1999
-
负责人:Terrence A. Barrett
-
依托单位:
T cell activation and crypt cell apoptosis
-
批准号:7384502
-
项目类别:
-
资助金额:$37.08万
-
财政年份:1999
-
负责人:Terrence A. Barrett
-
依托单位:
T CELL ACTIVATION AND CRYPT CELL APOPTOSIS
-
批准号:6624921
-
项目类别:
-
资助金额:$28.6万
-
财政年份:1999
-
负责人:Terrence A. Barrett
-
依托单位:
T cell activation and crypt cell apoptosis
-
批准号:6872169
-
项目类别:
-
资助金额:$29.47万
-
财政年份:1999
-
负责人:Terrence A. Barrett
-
依托单位:
国内基金
海外基金
UMSC-Exo通过调控Ribosome biogenesis诱导心肌再生的策略及机制研究
-
批准号:82370264
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:李杨欣
-
依托单位:
活体动物线粒体biogenesis、fission及fusion对肝脏再生中能量供应影响机制的研究
-
批准号:81470878
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:柳勤龙
-
依托单位: